0000950170-24-070563.txt : 20240607 0000950170-24-070563.hdr.sgml : 20240607 20240607160008 ACCESSION NUMBER: 0000950170-24-070563 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox Michael J CENTRAL INDEX KEY: 0001589232 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 241029129 MAIL ADDRESS: STREET 1: C/O PARK CITY CAPITAL, LLC STREET 2: 100 CRESCENT COURT SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 ownership.xml 4 X0508 4 2024-06-05 false 0001645460 Cue Biopharma, Inc. CUE 0001589232 Fox Michael J C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135 true false false false false Stock Option (right to buy) 1.65 2024-06-05 4 A false 48800 0.0 A 2034-06-04 Common Stock 48800 48800 D Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. This option was granted on June 5, 2024. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments /s/ Michael J. Fox by Colin Sandercock, attorney-in-fact 2024-06-07